Quai.MD
Shahar Botzer is a Co-Founder and Managing Partner at Good Company, a venture capital fund established in October 2020 that focuses on investing in leaders of the new economy addressing major global challenges. Botzer serves as a Pre-seed Investor and Board Member for multiple companies, including Beteende, Agave Health, Jotit, Mellie, and TaTiO, and holds the role of Pre-seed Investor for Quai.MD, MARINE EDGE, and Rhino Eco, as well as a Seed Investor for FeelBetter LTD. Shahar Botzer's academic background includes studies at Tel Aviv University, the University of Oxford, and the Mamram Academy for Computer Professions of the IDF.
This person is not in the org chart
This person is not in any teams
Quai.MD
Quai mitigates care variability by standardizing physician’s decision making with an AI-based platform for personalized clinical pathways. Clinical pathways are decision trees, defined based on medical research, for patients with a certain condition. Quai captures these pathways, personalizes them using its proprietary AI-engine, and presents them to the physician at the point of care. Physicians trust our platform because it builds on evidence-based pathways. Physicians love our platform because we make those pathways accessible, translating them into a live and interactive click-through tool that is embedded within their workflow. Physicians feel empowered by our platform because our AI-engine tailors the pathway to the specific patient, while allowing physicians full flexibility to choose whatever path they see fit.